CarthroniX is a biopharmaceutical company focused on developing small molecule-based therapies for degenerative and aging-related diseases, including arthritis. Our novel technologies are able to preserve, repair and regenerate cartilage in joints and concurrently suppress inflammation. We are also developing completely novel solutions for wound healing, skin regeneration and prevention of tissue fibrosis in the skin and musculoskeletal tissues. Our discoveries are based on science conducted by world-class researchers at iconic institutions. We are CarthroniX! We are the future!